MarkNtel Advisors recently published a detailed industry analysis of the Global Dry Eye Syndrome Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.

Global Dry Eye Syndrome Market, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030

The Dry Eye Syndrome Market size is valued at around USD 5.2 billion in 2023 and is projected to grow at a CAGR of around 4.21% during the forecast period, i.e., 2024-30.

Key Findings in Global Dry Eye Syndrome Market:

• Historical Analysis: 2019–2022
• Base Year: 2023
• Forecast Period: 2024–2030

Leading Market Players- Mitotech Pharma, ReGen Tree, Santen Pharmaceutical, HanAll Biopharma, Sun Pharma, Novaliq, Sylentis, Alcon, Horus pharma, Johnson& Johnson, Aldreya Therapeutics, Visufarma, Allergen, Prestige Consumer Health, Others

Key Highlights of the Report

• Market Dimensions & Projections
• Pricing Evaluation,
• Recent Strategic Moves by Companies,
• Primary Stakeholders,
• Analysis of Import and Export Trends,
• Competitive Landscape Assessment,
• Emerging Opportunities,
• Market Trends and Indicators

What are the major Driver the Global Dry Eye Syndrome Market?

Growing Number of Eye Care Centers Prompting Surge in Product Utilization – The prevalence of dry eye disease has been increasing worldwide, owing to various reasons such as environmental conditions, hormonal changes, a rise in the geriatric population, autoimmune disorders, etc. This has resulted in a spike in eye clinics & centers globally for treatment. Additionally, the blossoming of eye care centers is majorly driven by the steady boost in professionals, such as ophthalmologists & optometrists. While the number of ophthalmologists is expected to remain stable, the number of optometrists is presumed to raise.

Optometrists offer services through private practices, chain/mass merchandisers, and government organizations. Independent optometrists can differentiate themselves by providing personalized care, building patient loyalty, and offering clinical care. Hence, this allows them to offer a higher level of service to the patients. Thus, the growing number of eye care centers is prompting a surge in product utilization of DED & would propel its demand in the forecast years.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

https://www.marknteladvisors.com/query/request-sample/dry-eye-disease-drugs-market.html

What segments define the Global Dry Eye Syndrome Market from 2024 to 2030? How do these segments contribute to market dynamics and growth?

By Product

• Artificial Tears- Market Size & Forecast 2019-2030, USD Million
• Anti-inflammatory Drugs- Market Size & Forecast 2019-2030, USD Million
• Cyclosporine-- Market Size & Forecast 2019-2030, USD Million
• Corticosteroid-- Market Size & Forecast 2019-2030, USD Million
• Punctal Plugs- Market Size & Forecast 2019-2030, USD Million
• Dissolvable-- Market Size & Forecast 2019-2030, USD Million
• Removable-- Market Size & Forecast 2019-2030, USD Million
• Others (Secretagogues, Oral drugs, etc.)- Market Size & Forecast 2019-2030, USD Million

According to report, Anti-inflammatory drugs are among the most prevailing treatments for dry eye disease & have a high contribution in expanding the market size, hence driving the market growth.

By Disease Type

• Aqueous Dry Eye - Market Size & Forecast 2019-2030, USD Million
• Evaporative Dry Eye - Market Size & Forecast 2019-2030, USD Million

By Distribution Channel

• Offline- Market Size & Forecast 2019-2030, USD Million
• Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million
• Hospital Pharmacies - Market Size & Forecast 2019-2030, USD Million
• Online- Market Size & Forecast 2019-2030, USD Million

According to report, The Offline segment held a significant share of the Global Dry Eye Disease Market.

By Competition

• Competition Characteristics
• Market Share Analysis

Explore the Complete Global Dry Eye Syndrome Market Analysis Report – https://www.marknteladvisors.com/research-library/dry-eye-disease-drugs-market.html

Geographical Analysis: Global Dry Eye Syndrome Market

 By Region

• North America
• South America
• Europe
• The Middle East & Africa
• Asia-Pacific

Global Dry Eye Syndrome Market Recent Development:

• 2023: Novaliq & Bosch+Laumb announced the publication of pivotal phase 3 data of their ophthalmic drug NOVO3, which is developed to treat the signs & symptoms of Dry Eye Disease associated with meibomian gland dysfunction.

• 2022: Santen Pharmaceutical launched its dry-eye treatment DIQUAS® LX Ophthalmic Solution in Japan, which is an improved formulation to reduce administration frequency to three times daily & ease the patient burden.

Key Questions Addressed in This Study

• What are the primary factors driving the growth of the Global Dry Eye Syndrome Market?
• How is the Global Dry Eye Syndrome Market expected to evolve over the next five years?
• What key insights can be drawn from current trends shaping the market?
• What is the current market size, and how is it forecasted to change in the coming years?
• What is the future outlook for the market in terms of technological innovation and geographic expansion?

For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/dry-eye-disease-drugs-market.html

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

More Research Studies Report:

-Biocomposites Market size was valued at around USD 36.9 billion in 2025 and is projected to reach USD 89 billion by 2030 with a CAGR of around 119.27%.

-Green Solvents Market size was valued at around USD 1.34 billion in 2025 & is projected to reach USD 1.87 billion by 2030 with a CAGR of around 5.7%.

For Media Inquiries, Please Contact:

Email: sales@marknteladvisors.com

Trending Blogs : www.marknteladvisors.com/blogs

Export-import Data : https://www.marknteladvisors.com/export-import-data